Skip to content

Clinical trials

Completed Carcinoma in Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20091
20102
20112
20121
20132
20141
20153
20174
20183
20191
20203
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
National Cancer Institute (NCI)2
Protara Therapeutics2
Anandasabapathy, Sharmila, M.D.1
Bioniche Life Sciences Inc.1
CG Oncology, Inc.1
Children's Oncology Group1
ECOG-ACRIN Cancer Research Group1
Endo USA Inc., a Keenova Therapeutics Company1
Hiantis Srl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ32
Urinary Bladder Neoplasms7
Neoplasms6
Breast Neoplasms4
Non-Muscle Invasive Bladder Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Uterine Cervical Dysplasia4
Papillomavirus Infections3
Uterine Cervical Neoplasms3
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.